The main challenge for production of insulin using rDNA technique was getting insulin assembled into a mature form.

Insulin is a hormone that is naturally produced in the pancreas and is responsible for regulating blood sugar levels. However, for individuals with diabetes, their bodies either do not produce enough insulin or do not use it effectively. Therefore, insulin replacement therapy is necessary to manage their condition.

Traditionally, insulin used for therapy was derived from animal sources, such as pigs and cows. However, these animal-derived insulins posed several challenges, including potential allergic reactions and limited supply. To overcome these limitations, scientists turned to recombinant DNA (rDNA) technology to produce synthetic human insulin.

Recombinant DNA (rDNA) technology:
Recombinant DNA technology involves the manipulation of genetic material to produce desired proteins. In the case of insulin production, the human gene responsible for insulin production is inserted into a bacterial or yeast host, which then produces large quantities of human insulin.

The challenges:
While the overall process of producing insulin using rDNA technology is relatively straightforward, there were several challenges that scientists had to overcome:

1. Removing the C peptide chain:
- Insulin is initially produced as a single polypeptide chain known as proinsulin, which consists of an A chain, a C peptide chain, and a B chain.
- To obtain mature insulin, the C peptide chain needs to be removed.
- This challenge was successfully addressed by introducing specific enzymes that cleave the C peptide chain, resulting in the formation of mature insulin.

2. Joining chain A with the peptide chain:
- After removing the C peptide chain, scientists needed to ensure that the remaining A and B chains were correctly joined together.
- This was achieved by introducing disulfide bonds between the A and B chains, which stabilize the insulin molecule.

3. Separating chain A and chain B:
- During the production process, it is important to separate the A and B chains from other impurities.
- Various purification techniques, such as chromatography, were employed to isolate the A and B chains and remove any contaminants.

4. Getting insulin assembled into a mature form:
- Once the A and B chains were separated and purified, the final challenge was to ensure that they properly assembled into a mature insulin molecule.
- This required careful monitoring of the folding and assembly process to ensure the correct three-dimensional structure of insulin.

Conclusion:
While each of the challenges mentioned above was significant, the main challenge in the production of insulin using rDNA technology was getting insulin assembled into a mature form. This involved addressing the complexities of folding and assembly to ensure the production of a functional insulin molecule.